On November 27, 2013, Medgenics, Inc. announced that Clarence L. Butch Dellio, the company's Chief Operating Officer, and Marvin R. Garovoy, the company's Chief Medical Officer, of the termination of their respective employment agreements, effective December 31, 2013.
Aevi Genomic Medicine, Inc.
Equities
US00835P1057
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |